Makers Laboratories valuation

Share price at each year-end
Tap a line for its trendCurrentlast closeFY26Mar 2026FY24Mar 2024FY23Mar 2023
Price multiples — at each FY-end close
2.05×———
2.22×———
Enterprise multiples
2.27×———
156.71×———
−55.22×———
Yield
−1.5%———
−2.1%———
Reference — adjusted share basis
₹189.18———
−₹2.91−₹2.91−₹11.76−₹10.76
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

MAKERSL₹189.18

Makers Laboratories Limited

· Pharma & Health
₹ CrorePeersBPLPHARMAJENBURPHKPLNOVARTINDPARNAXLABSGRLSHUKRAPHARSUNLOCMcap ₹112 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
Multiples — ₹ Crore base
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current
last close
Price Multiples — at each FY-end close
P/B————2.05
P/Sales————2.22
Enterprise Multiples
EV/Sales————2.27
EV/EBITDA————156.71
EV/EBIT————-55.22
Yield
Earnings Yield %————-1.54
FCF Yield %————-2.09
Reference — adjusted share basis
Price (FY-end close, adj.)————189.18
EPS (adj.)-10.76-11.76—-2.91-2.91
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.